VHL Ligand-Linker Conjugates 15
98%
- Product Code: 106541
CAS:
2375564-62-6
| Molecular Weight: | 724.84 g./mol | Molecular Formula: | C₃₇H₄₅FN₄O₈S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, dry, sealed |
Product Description:
VHL Ligand-Linker Conjugates 15 is primarily utilized in the field of targeted protein degradation, particularly in the development of PROTACs (Proteolysis Targeting Chimeras). These conjugates play a crucial role in designing molecules that can selectively degrade disease-causing proteins by recruiting the ubiquitin-proteasome system. The VHL ligand component specifically binds to the von Hippel-Lindau E3 ubiquitin ligase, enabling the targeted degradation of proteins of interest. This approach is highly valuable in drug discovery, especially for treating conditions like cancer, neurodegenerative diseases, and other disorders driven by aberrant protein activity. Its application allows for the precise manipulation of cellular protein levels, offering a novel therapeutic strategy beyond traditional inhibition methods.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿99,000.00 |
+
-
|
VHL Ligand-Linker Conjugates 15
VHL Ligand-Linker Conjugates 15 is primarily utilized in the field of targeted protein degradation, particularly in the development of PROTACs (Proteolysis Targeting Chimeras). These conjugates play a crucial role in designing molecules that can selectively degrade disease-causing proteins by recruiting the ubiquitin-proteasome system. The VHL ligand component specifically binds to the von Hippel-Lindau E3 ubiquitin ligase, enabling the targeted degradation of proteins of interest. This approach is highly valuable in drug discovery, especially for treating conditions like cancer, neurodegenerative diseases, and other disorders driven by aberrant protein activity. Its application allows for the precise manipulation of cellular protein levels, offering a novel therapeutic strategy beyond traditional inhibition methods.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :